NCT03433781: A Phase Ib Study Evaluating the Safety and Tolerability of Vitamin C in Patients With Intermediate or High Risk Myelodysplastic Syndrome With TET2 Mutations |
|
|
| Completed | 1/2 | 4 | US | Vitamin C, ascorbic acid, ascorbate | NYU Langone Health, Perlmutter Cancer Center | Myelodysplastic Syndromes | 11/22 | 05/23 | | |